Clinical Trials on Tick-borne Encephalitis

Total 26794 results

National Institute of Allergy and Infectious Diseases...
National Institutes of Health (NIH)

Terminated

Vaccine Study for Tick-Borne Encephalitis Virus (TBEV) (TBEV)

Tick-Borne Disease | Encephalitis, Tick-Borne | Tick-Borne Encephalitis | Glycoprotein E, Flavivirus | NSI Protein, Flavivirus

United States
Medical University of Vienna
Austrian Science Fund (FWF)

Completed

Humoral and Cellular Immunity for TBE Vaccination in Allogeneic HSCT Recipients

Tick Borne Encephalitis

Austria
Pfizer

Completed

TBE Seropersistence up to 10 Years After First Booster in Adults

Tick-borne Encephalitis (TBE)

Poland
University Medical Centre Ljubljana
University of Ljubljana School of Medicine, Slovenia

Recruiting

Tick-borne Encephalitis and Borrelial Antibodies in Serum

Tick Borne Encephalitis

Slovenia
University of Surrey

Completed

Cervicovaginal Immune Responses to 3 Deltoid or Thigh Intramuscular (IM) TicoVac (CRC306)

Tick-Borne Encephalitis

United Kingdom
Elisabethinen Hospital
Baxter Healthcare Corporation; ASOKLIF

Unknown

Evaluation of Immunogenicity of Different Tick Borne Encephalitis (TBE) Fast Protective Traveler Schemes With Inactivated TBE Whole Virus Vaccine (immunisation)

Tick Borne Encephalitis

Austria, Czech Republic
Sykehuset Telemark
Norwegian Institute of Public Health; Oslo University Hospital; Sorlandet Hospital... and other collaborators

Recruiting

The Norwegian Tick Born Encephalitis Study (NOTES)

Tick-Borne Encephalitis, European

Norway
Pfizer

Completed

Study to Evaluate the Immunogenicity, Safety, and Tolerability of a Tick-Borne Encephalitis (TBE) Vaccine in Healthy Japanese Participants 1 Year of Age and Older

Tick-Borne Encephalitis

Japan
GlaxoSmithKline
Novartis Vaccines

Completed

Study to Evaluate Long Term Immunogenicity up to 10 Years After the First Booster Immunization With Tick Borne Encephalitis Vaccine in Adults Who Received 1 of 3 Different Primary Vaccination Schedules

Virus Diseases | Tick Borne Encephalitis

Czechia
Novartis Vaccines

Completed

An Extension Study to Determine the Persistence of Tick-borne Encephalitis (TBE)-Specific Antibody Responses Among Children and Adolescents Previously Immunized Against TBE

Tick Borne Encephalitis (TBE)

Germany
National Institute of Allergy and Infectious Diseases...
Johns Hopkins Bloomberg School of Public Health

Completed

Safety of and Immune Response to a Tick-Borne Encephalitis Vaccine (LGT(TP21)/DEN4) in Healthy Adults

Tick-Borne Encephalitis

United States
Medical University of Vienna

Unknown

Application of a TBE-Vaccine in Obese Persons

Tick Borne Encephalitis

Austria
Pfizer

Completed

FSME IMMUN NEW Follow-up to Study 199 in Children Aged 1 to 6 Years

Encephalitis, Tick-borne

Austria, Germany
University Hospital, Limoges

Recruiting

Tick-borne Encephalitis Virus Research in Limousin (VITAL)

Tick-borne Encephalitis

France
University Hospital, Strasbourg, France

Recruiting

Prevalence of Tick-borne Encephalitis in the Pediatric Population Treated at the HUS and Characterization of Confirmed Pediatric Cases (TBE-KID)

Tick-borne Encephalitis

France
Pfizer

Completed

Immunogenicity and Safety Study of a Third Vaccination With FSME-IMMUN 0.5 mL in Subjects Previously Vaccinated According to a Rapid Immunization Schedule (Follow-up to Study 225)

Encephalitis, Tick-borne

Belgium
Pfizer

Completed

Study to Investigate the Seropersistence of TBE Virus Antibodies Approx. 3 Years After a Booster Vaccination With FSME-IMMUN 0.25 mL JUNIOR in Children

Encephalitis, Tick-borne

Austria
Pfizer

Completed

Immunogenicity and Safety Study of a Rapid Immunization Schedule With FSME-IMMUN 0.5 mL in Healthy Adults Aged 16 - 65 Years

Encephalitis, Tick-borne

Belgium
Pfizer

Completed

Investigation of the Seropersistence of TBE Antibodies and the Booster Response to FSME-IMMUN 0.5 ml in Adults Aged 18 - 67 Years

Tick-borne Encephalitis

Poland
Pfizer

Completed

Safety and Immunogenicity Study of 3 Vaccinations With TICOVAC in 2 Dosages in Healthy Children Aged Between 6 Months and 3 Years

Encephalitis, Tick-borne

Austria
Pfizer

Completed

Dose-finding Study to Investigate the Safety and Immunogenicity of Two Vaccinations With FSME IMMUN NEW in Healthy Volunteers Aged 1 to 6 Years.

Tick-borne Encephalitis

Austria, Germany
Pfizer

Completed

Dose-finding Study to Investigate the Safety and Immunogenicity of Two Vaccinations With FSME IMMUN NEW in Healthy Volunteers Aged 6 to 16 Years.

Tick-borne Encephalitis

Germany
Pfizer

Completed

FSME IMMUN NEW Follow-up to Study 208 in Volunteers Aged 16 to 66 Years

Encephalitis, Tick-borne

Poland
Medical University of Vienna

Completed

Humoral and Cellular Immunity of Low and High-responders After Tick-borne Encephalitis Vaccination

Tick-borne Encephalitis

Austria
University Medical Centre Ljubljana

Unknown

Postencephalitic Symptoms After Tick Borne Encephalitis

Central European Encephalitis

Slovenia
University Medical Centre Ljubljana
University of Ljubljana School of Medicine, Slovenia

Completed

Tick-borne Encephalitis and Possible Borrelial Serology

Lyme Disease | Tick Borne Encephalitis

Slovenia
Pfizer

Completed

Safety Study in Volunteers From 16 to 65 Years of Age: FSME IMMUN NEW vs. ENCEPUR

Encephalitis, Tick-borne

Poland
Pfizer

Completed

FSME IMMUN NEW Follow-up to Study 205 in Children Aged 6 to 16 Years

Encephalitis, Tick-borne

Germany
Region Örebro County

Not yet recruiting

Primary TBE Vaccination for the Elderly

Vaccine | Tick-borne Encephalitis

Sweden
Sormland County Council, Sweden
Karolinska Institutet; Helsingfors university

Completed

New Study - Humoral Response to Tick-borne Encephalitis Vaccine in Elderly

Tick-borne Encephalitis

Sweden, Finland
Pfizer

Completed

Tick-Borne Encephalitis (TBE) Seropersistence After First Booster and Response to a Second Booster in Children, Adolescents and Young Adults (Follow-Up to Study 700401)

Encephalitis, Tick-Borne

Austria, Germany, Poland
University Medical Centre Ljubljana
University of Ljubljana School of Medicine, Slovenia

Unknown

Tick-borne Encephalitis and Positive Borrelial Antibodies (TBE-LB2014)

Tick-borne Encephalitis

Slovenia
Sormland County Council, Sweden

Completed

Humoral Response to Tick-borne Encephalitis Vaccine in Elderly

Tick-borne Encephalitis

Finland, Sweden
Pfizer

Completed

Safety Study of FSME-IMMUN NEW in Healthy Children and Adolescents Aged 1 to 15 Years

Tick-borne Encephalitis

Austria, Germany, Poland
Göteborg University
Vastra Gotaland Region; Sahlgrenska University Hospital, Sweden

Unknown

Fever After Tick Bite Study (FATB)

Tick-Borne Diseases | Encephalitis, Tick-Borne | Tick Bites | Tick-Bite; Fever | Tick Fever

Sweden
Pfizer

Completed

Immunogenicity and Safety Study of FSME-IMMUN 0.5 mL in Adult Subjects Previously Vaccinated According to a Rapid Immunization Schedule

Encephalitis, Tick-Borne

Poland
Novartis
Novartis Vaccines

Completed

Study of the Safety, Tolerability and Immune Response of TBE Vaccines Administered to Healthy Children

Encephalitis, Tick-Borne

Germany
Novartis
Novartis Vaccines

Completed

Evaluation of Long-Term Immunogenicity in Children and Adolescents Boosted With a New Pediatric TBE Vaccine After Five Years

Encephalitis, Tick-Borne

Germany
Novartis
Novartis Vaccines

Completed

Evaluation of Long-Term Immunogenicity in Subjects Boosted With a TBE Vaccine for Adults

Encephalitis, Tick-Borne

Germany
Novartis Vaccines

Completed

Safety and Long-term Evaluation (up to 5 Years) of First Booster Immunization With Novartis' TBE Vaccine for Adults in Adolescents and Adults

Tick Born Encephalitis

Czech Republic
Medical University of Vienna

Completed

TBE (Tick-borne Encephalitis) Vaccination in Allergic Patients

Vaccine Responsiveness in Allergy | Vaccine Responsiveness During Allergy De-sensitization Treatment

Austria
Pfizer

Completed

TBE Antibody Persistence and Booster Vaccination Study in Adults (Follow-up to Study 223)

Encephalitis, Tick-Borne

Poland
Pfizer

Completed

TBE Antibody Persistence and Booster Vaccination Study in Children and Adolescents (Follow-up to Study 209)

Encephalitis, Tick-Borne

Germany, Austria, Poland
Pfizer

Completed

Immunogenicity, Safety and Interchangeability of Two Tbe Vaccines Administered According to a Conventional Schedule in Children

Encephalitis, Tick-Borne

Austria, Czechia
GlaxoSmithKline

Completed

The Aim of This Study is to Investigate the Persistence of Antibody Response in Adults up to 15 Years After One Booster Dose of GlaxoSmithKline (GSK) Biologicals' Encepur Adults Vaccine

Virus Diseases

Czechia
University of Zurich
Division of Infectious Diseases and Hospital Epidemiology

Completed

Influence of Persistent CMV-infection on Immune Senescence

Immune Senescence

Switzerland
IRCCS Sacro Cuore Don Calabria di Negrar

Recruiting

Insights Into Tick-Borne Diseases: a Study From an Endemic Area of Northern Italy (TICKTOC)

Tick-Borne Diseases

Italy
National Institute of Allergy and Infectious Diseases...

Withdrawn

Evaluation and Follow-up of People With Tick-borne Diseases

Lyme Disease | Tick-Borne Disease

United States
University Hospital, Strasbourg, France

Unknown

Human Anaplasmosis in Eastern France

Anaplasmosis | Tick-borne Disease | Ehrlichia

France
University of North Carolina, Chapel Hill
National Institute for Occupational Safety and Health (NIOSH/CDC); East Carolina... and other collaborators

Completed

Tick-borne Illness and Clothing Study of Rhode Island

Tick Bites | Tick-borne Diseases

United States

3

Subscribe